|
Two Tampa Bay Rays minor-leaguers suspended
Two players on the Tampa Bay Rays Venezuelan Summer League team, OF Franklin Alcala and LHP Carlos Orasma, were suspended for 50 games each for testing positive for performance-enhancing drugs.
The two tested positive for metabolites of Nandrolone, a performance-enhancing substance, which is in violation of the Minor League Drug Prevention and Treatment Program.
The suspensions are effective immediately. Orasma, 17, is listed in the Rays media guide as a 5-foot-9, 154-pounder who signed last October. In six appearances for the VSL Rays, he is 2-0, 3.86 with 19 strikeouts in 16 1/3 innings. Alcala is not in the media guide. In 12 games, he hit .086 with 19 strikeouts in 35 at-bats.
Rays executive VP Andrew Friedman said: “We’re very supportive of Major League Baseball’s policy. This is something that we take very seriously. We have a lot of measures in place to educate our players, especially in Latin America, about the policy and the negative effects that this can have both personally and professionally.”
Most Recent Blog Posts
Advertisement
Meet the Rays
Joe Maddon, Johnny Damon and Evan Longoria are only some of the Rays you'll meet through our new video interview series. Don't see your favorite player yet? Check back often, as we'll add to the series as the season progresses.
Most Popular Categories
Baseball Headlines from AP
Comment Policy
| Please be sure your comments are appropriate before submitting them. Inappropriate comments include content that: |
| Is libelous |
| Is abusive, harassing, or threatening |
| Is obscene, vulgar, or profane |
| Is racially, ethnically or religiously offensive |
| Is illegal or encourages criminal acts |
| Is known to be inaccurate or contains a false attribution |
| Infringes copyrights, trademarks, publicity or any other rights of others |
| Impersonates anyone (actual or fictitious) |
| Solicits funds, goods or services, or advertises |
| The Tampa Bay Times does not edit posts but reserves the right to delete comments that violate our policy. |